MuhamadAlhaj MoustafaMD, MS

Hematology • Jacksonville, FL

Hematologic Oncology

Assistant Professor of Medicine at Mayo Clinic School of Medicine.

Join to view full profile

Dr. Alhaj Moustafa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Alhaj Moustafa's full profile

Already have an account?

Office
4500 San Pablo Road S
Jacksonville, FL 32224
Is this information wrong?

Summary

Muhamad Alhaj Moustafa, MD, MS, is a Hematologist and Medical Oncologist, with specialty interest in Lymphoma, Cellular Therapy, and Histiocytic diseases.

Dr. Alhaj Moustafa's primary emphasis in the clinic is to enhance patients' comprehension of their condition and encourage them to participate as active partners in their healthcare management.

Apart from his clinical responsibilities, Dr. Alhaj Moustafa is actively involved in research and education, serving as a mentor to medical students, residents, and fellows.

My Bibliography

Complete list of publication

Education & Training

Mayo Clinic Graduate SchoolMaster, Clinical and Translational Science , 2019 - 2022
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2018 - 2021
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2015 - 2018
Mayo Clinic Graduate SchoolDiploma, Clinical and Translational Science , 2014 - 2015
Mayo Clinic College of MedicinePost-Doctoral Fellowship, The Gene and Mary Lou Kurtz Research Fellow in Multiple Myeloma, 2014 - 2015
Mayo Clinic College of MedicinePost-Doctoral Fellowship, Clinical Research- Hematology, 2013 - 2014
University of Aleppo Faculty of MedicineClass of 2013

Certifications & Licensure

FL State Medical License 2018 - 2026
DC State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
National Institute of Health (NIH) Clinical CenterIntroduction to the Principles and Practice of Clinical Research

Awards, Honors, & Recognition

Robert A. Winn Diversity in Clinical Trials Award Program
Top Teacher Award Internal Medicine Residency Program at Mayo Clinic in Florida, 2022-2023
Educator of the year Hematology Oncology Fellowship Program at Mayo Clinic in Florida, 2022-2023
Mayo Clinic Experience Top Performer Award Mayo Clinic, 2022
ASCO Travel Award Florida Society of Clinical Oncology (FLASCO), 2020
COA Fellows Scholarship Community Oncology Association, 2019
ASH Travel Award Florida Society of Clinical Oncology (FLASCO), 2019
ASH Abstract Achievement Award American Society of Hematology, 2019
Young Investigator Travel Grant (09/17/2014- 09/20/2014) SOHO (Society of Hematologic Oncology) Annual Meeting, 2014
Join now to see all

Clinical Trials

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma Start of enrollment: 2021 Sep 15
Recruiting
Phase 1
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) Start of enrollment: 2019 May 20
Recruiting
Phase 1, Phase 2
Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL Start of enrollment: 2022 Jul 05
Terminated
Phase 1, Phase 2
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome Start of enrollment: 2021 Oct 21
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma.
Alhaj Moustafa, M., Salman J Khan, Muhamad Alhaj Moustafa> ;Chinese Clinical Oncology. 2024 Apr 1
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma.
Muhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, Farhad Khimani, Bhagirathbhai Dholaria, Leyla Bojanini, Taylor Brooks, Jasmine Zain, N Nora Bennani, ...> ;Transplantation and Cellular Therapy. 2024 May 1
Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for ...
Li, K., Mosalem, O., Pai, T., Alqawasma, M., Shaikh, M., Alhaj Moustafa, M.> ;Journal of Blood Medicine. 2024 Jan 1
Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis.
Emily B Wolf, David Li, Andre J Fernandez, Lindsay B Gardner, Candido E Rivera, Ewa M Wysokinska, Marwan E Shaikh, Han W Tun, Vivek Roy, Muhamad Alhaj Moustafa> ;Journal of Investigative Medicine High Impact Case Reports. 2023 Nov 3
1 citations
Severe Insulin Resistance in a Patient Treated With Nivolumab and Brentuximab-Vedotin for Hodgkin Lymphoma.
Elif Tama, Meghan Black, Muhamad Alhaj Moustafa, Maria D Hurtado> ;JCEM Case Reports. 2023 Nov 1
1 citations
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma.
Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, Patrick B J...> ;Haematologica. 2023 Nov 1
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, Vivek Roy, Taimur Sher, Victoria R Alegria, Rahma M Warsame, Rafael Fonseca, Ahsan Rasheed, Wilson I Gonsa...> ;Anti-Cancer Drugs. 2024 Jan 1
Timing of CAR-T therapy in follicular lymphoma.
Muhamad Alhaj Moustafa> ;Expert Review of Anticancer Therapy. 2023 Apr 1
2 citations
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, m...
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqba...> ;American Journal of Hematology. 2023 May 1
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
Muhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, Ruchita Dholakia, Liuyan Jiang, Ke Li, Thomas E Witzig, Bradford S Hoppe, Jennifer Peterson, James R Cerhan, H...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Apr 1
Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma.
Jordan Davis, ErinMarie O Kimbrough, Muhamad Alhaj Moustafa, Liuyan Jiang, Vivek Gupta, Ephraim Parent, Han W Tun> ;Journal of Blood Medicine. 2023 Jan 1
Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases.
Jing Wang, Firas Baidoun, Han W Tun, Muhamad Alhaj Moustafa> ;Blood and Lymphatic Cancer. 2023 Jan 1
Brief report: risk stratification following curative therapy for stage I NSCLC.
Emily Butts, Denise Gococo-Benore, Tanmayi Pai, Muhamad Alhaj Moustafa, Fei Heng, Ruqin Chen, Yujie Zhao, Rami Manochakian, Yanyan Lou> ;Frontiers in Oncology. 2023 Jan 1
Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy.
Lyndsey L Fournier, ErinMarie O Kimbrough, Muhamad Alhaj Moustafa, Ke Li, Madiha Iqbal, Vivek Gupta, Han W Tun> ;Journal of Blood Medicine. 2023 Jan 1
End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET.
Karan L Chohan, Jason R Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Rosenthal, Han W Tun, Bradford S Hoppe, Patrick B Johnston, Ivana N Micallef, Thomas M Hab...> ;Haematologica. 2023 Jun 1
6 citations
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma.
Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, N Nora Benn...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Aug 1
Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphoma.
Madiha Iqbal, Liuyan Jiang, Ke David Li, Muhamad Alhaj Moustafa, ErinMarie O Kimbrough, Stephen M Ansell, Han W Tun> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Feb 1
2 citations
Management of CAR T-cell Related Toxicities: What did the Learning Curve Teach us so Far?
Hemant S Murthy, Farah Yassine, Madiha Iqbal, Shaikha Alotaibi, Muhamad Alhaj Moustafa, Mohamed A Kharfan-Dabaja> ;Hematology/oncology and Stem Cell Therapy. 2022 Nov 7
1 citations
Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma: A Game Changer?
Razan Mohty, Muhamad Alhaj Moustafa, Mahmoud Aljurf, Hemant Murthy, Mohamed A Kharfan-Dabaja> ;Hematology/oncology and Stem Cell Therapy. 2022 Nov 7
3 citations
Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell Therapy.
Madiha Iqbal, Radhika Bansal, Farah Yassine, Sangeetha Gandhi, Allison Rosenthal, Muhamad Alhaj Moustafa, Zhuo Li, Emily C Craver, Razan Mohty, Hemant Murthy, Ernesto ...> ;Transplantation and Cellular Therapy. 2022 Oct 1
3 citations
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018).
Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, Umair Majeed, Jing Wang, Liuyan Jiang, Justin Kuhlman, David Menke, Ke Li, Mohamed A Kharfan-Dabaja, Ernesto Ayala, Ma...> ;American Journal of Hematology. 2022 Sep 1
5 citations
A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome.
Karan L Chohan, Jason R Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Rosenthal, Han W Tun, Bradford S Hoppe, Patrick B Johnston, Ivana N Micallef, Thomas M Hab...> ;Blood Advances. 2022 Jul 26
Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alt...
Jing Wang, Muhamad Alhaj Moustafa, Justin J Kuhlman, Karan Seegobin, Liuyan Jiang, Vivek Gupta, Han W Tun> ;Blood and Lymphatic Cancer. 2022 Jan 1
4 citations
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.
Sikander Ailawadhi, Ricardo D Parrondo, Muhamad Alhaj Moustafa, Betsy R LaPlant, Victoria Alegria, Dustin Chapin, Vivek Roy, Taimur Sher, Aneel Paulus, Asher A Chanan-...> ;Hematological Oncology. 2022 Oct 1
1 citations
Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma.
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, Jing Wang, Vivek Gupta, Han W Tun> ;Blood and Lymphatic Cancer. 2022 Jan 1
Join now to see all

Journal Articles

Medical Image of the Week: Malposition of Central Venous Catheter
Mohamad Muhailan, MD and Muhamad Alhaj Moustafa, MD, Southwest Journal of Pulmonary and Critical Care, 7/11/2018

Abstracts/Posters

Outcomes of Hematopoietic Cell Transplantation for Hepatosplenic T-Cell Lymphoma: A US Multicenter Collaborative Study
Muhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, Farhad Khimani, Bhagirathbhai Dholaria, Leyla Bojanini, Jasmine Zain, N Nora Bennani, Zachary Braunst..., Transplantation and Cellular Therapy, Orlando, FL, 2/1/2023
Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Primary Cutaneous CD30+ T-Cell Lymphoma: National Cancer Database Analysis (2004-2018)
Firas Baidoun, Jason Sluzevich, Han W Tun, Muhamad Alhaj Moustafa, American Society of Hematology, 11/15/2022
Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Lymphocyte-Depleted Hodgkin's Lymphoma: National Cancer Database Analysis (2004-2018)
Firas Baidoun, Bradford Hoppe, Han W Tun, Muhamad Alhaj Moustafa, American Society of Hematology, 11/15/2022
Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+ Treated with Daratumumab-Based Regimens: A Retrospective Analysis
Ricardo D Parrondo, Lindsay Brooke Gardner, Muhamad Alhaj Moustafa, Vivek Roy, Taimur Sher, Ahsan Rasheed, Rahma M Warsame, Jeremy T Larsen, Wilson I Gonsalves, Taxiar..., American Society of Hematology, 11/15/2022
Impact of ABO mismatch on survival and engraftment in haploidentical hematopoietic stem cell transplantation
BJ McCormick, R Mohty, M Alhaj Moustafa, M Iqbal, R Parrondo, E Ayala, J Foran, V Roy, B Savani, MA Kharfan-Dabaja, HS Murthy, BONE MARROW TRANSPLANTATION, 11/1/2022
Comprehensive Salvage Radiotherapy for Limited Relapsed B-Cell Non-Hodgkin Lymphoma Following CD19 Chimeric Antigen Receptor T-Cell Therapy
O Saifi, W Breen, SC Lester, WG Rule, BJ Stish, A Rosenthal, J Munoz, Y Lin, N Bennani, J Paludo, A Khurana, J Villasboas Bisneto, P Johnston, SM Ansell, M Iqbal, M Al..., International Journal of Radiation Oncology, Biology, Physics, 11/1/2022
Combined modality therapy for early-stage Hodgkin lymphoma in the PET era: A real-world study.
Karan Chohan, Jason R. Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Claire Rosenthal, Han W. Tun, Bradford Hoppe, Patrick B. Johnston, Ivana N. M. Micallef, Th..., 2022 ASCO Annual Meeting, 6/2022
In-field recurrences in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) bridged with radiation prior to CD19 chimeric antigen receptor T-cell therapy (CART).
mran Saifi, William Breen, Scott Lester, William G. Rule, Brad J. Stish, Allison Claire Rosenthal, Javier Munoz, Yi Lin, Nabila Nora Bennani, Jonas Paludo, Arushi Khur..., 2022 ASCO Annual Meeting, 6/2022
37P Obesity and ovarian cancer: A controversial risk factor
F Baidoun, J Abdeldayem, AM Saad, MT Sarmini, MM Gad, M Alhaj Moustafa, Annals of Oncology, 6/1/2022
Real-world Utilization and Cost-effectiveness of Yttrium-90 Ibritumomab Tiuxetan vs Bendamustine Plus Rituximab for FL and MZL
Muhamad Alhaj Moustafa, MD, Bijan J Borah, PHD, James P Moriarty, MS, Ruchita Dholakia, MS, MBA, Liuyan Jiang, MD, Bradford Hoppe, MD, MPH, Jennifer Peterson, MD, Jame..., American Society of Hematology, 12/13/2021
Characteristics, Management and Outcomes of Patients with Intravascular Lymphoma: A Mayo Clinic Experience
Karan Seegobin, MBBS, Muhamad Alhaj Moustafa, MD, Umair Majeed, MBBS, Liuyan Jiang, MD, David Menke, MD, Ke Li, MD, Mohamed A. Kharfan-Dabaja, MD, MBA, Ernesto Ayala, ..., American Society of Hematology, 12/11/2021
Salvage therapies in transplant-eligible relapsed classic Hodgkin lymphoma, are novel regimens better?
Sanjal Desai, Yucai Wang, Allison Claire Rosenthal, Craig B. Reeder, David James Inwards, Ernesto Ayala, Grzegorz S. Nowakowski, Han W. Tun, Jonas Paludo, Jose Caetano..., American Society of Clinical Oncology, Virtual, 5/28/2021
Diffuse large B-cell lymphoma with leukemic involvement.
Justin J. Kuhlman, Muhamad Alhaj Moustafa, Karan Seegobin, Madiha Iqbal, Ernesto Ayala, Stephen M. Ansell, Allison Claire Rosenthal, Jonas Paludo, Ivana N. M. Micallef..., American Society of Clinical Oncology, 5/28/2021
CD68+ Tumor Associated Macrophages Have Significant Impact on Therapeutic Outcome in Newly Diagnosed Multiple Myeloma (MM)
Ricardo Parrondo, MD, Muhamad Alhaj Moustafa, MD, Han W. Tun, MD, Liuyan Jiang, MD, American Society of Hematology, 11/5/2020
Efficacy of Daratumumab (Dara)-Based Regimens for the Treatment of Plasma Cell Leukemia (PCL)
Ricardo Parrondo, MD, Muhamad Alhaj Moustafa, MD, Craig B. Reeder, MD, Taimur Sher, MD, Vivek Roy, MD, Rahma M Warsame, MD, Victoria R. Alegria, Wilson I Gonsalves, MD..., American Society of Hematology, 11/5/2020
Daratumumab Plus Lenalidomide and Dexamethasone (DRd) Compared to Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Relapsed Lenalidomide-Exposed or Refractory ...
Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Mays F Abdulazeez, MBBS, Vivek Roy, MD, Taimur Sher, MD, Victoria R. Alegria, Rahma M Warsame, MD, Jeremy Larsen, Wil..., AMerican Society of hematology, 11/5/2020
Identifying areas for quality improvement through outpatient mortality review
Denise Gococo-Benore, Adam McLain Kase, Umair Majeed, Muhamad Alhaj Moustafa, Ruqin Chen, Sree Battu, Molly Kilpatrick, Maisha Robinson, Jennifer Cowart, Alvaro Moreno..., Journal of Clinical Oncology, 10/10/2020
Identifying areas for quality improvement through outpatient mortality review
Denise Gococo-Benore, Adam McLain Kase, Umair Majeed, Muhamad Alhaj Moustafa, Ruqin Chen, Sree Battu, Molly Kilpatrick, Maisha Robinson, Jennifer Cowart, Alvaro Moreno..., ASCO 2020 - QUALITY, SAFETY, AND IMPLEMENTATION SCIENCE, Virtual, 10/10/2020
AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR DOUBLE HIT LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Omran Saifi, Muhamad Alhaj Moustafa, MD, Tea Reljic, Madiha Iqbal, MD, Ernesto Ayala, MD, Ambuj Kumar, Mohamed Kharfan-Dabaja, MD, the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2020), Madrid, Spain, 3/22/2020
Autologous Stem Cell Transplant for Waldenström Macroglobulinemia in the Era of Novel Therapies: Still an Underutilized Tool?
Ricardo D. Parrondo, MD, Muhamad Alhaj Moustafa, MD, Prashant Kapoor, MD, Vivek Roy, MD, Craig Reeder, MD, Sikander Ailawadhi, MD, Transplantation and Cellular Therapy Meeting, World Center Marriott in Orlando, FL, 2/19/2020
A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
Anthony R. Mato, MD MSCE, Stephen J Schuster, MD, Francine M. Foss, MD4, Iris Isufi, MD, Wei Ding, MD, PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Han W. Tun, ..., American Society of Hematology, Orlando, FL, 12/9/2019
Long-Term Outcome of Patients with Low-Grade Follicular Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Gregory Wiseman, MD, Jennifer Peterson, MD, Thomas E. Witzig, MD, Han W. Tun, MD, American Society of Hematology, Orlando, 12/8/2019
Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Gregory Wiseman, MD, Jennifer Peterson, MD, Thomas E. Witzig, MD, Han W. Tun, MD, American Society of Hematology, Orlando, FL, 12/7/2019
Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
Sikander Ailawadhi, MD, Aneel Paulus, MD, Victoria R. Alegria, Betsy Laplant, MS, Muhamad Alhaj Moustafa, MD, Dustin Chapin, Keisha Jackson, Prachi Jani, MD, Salman Ah..., American Society of Hematology, Orlando, FL, 12/7/2019
Back to the basics: Etoposide neurotoxicity in a patient with high grade B-cell lymphoma
Muhamad Alhaj Moustafa, MD, Taimur Sher, MD, THE 2019 FLASCO BUSINESS OF ONCOLOGY SUMMIT AND SPRING SESSION, Orlando, FL, 4/12/2019
Join now to see all

Lectures

Updates in the management of diffuse large B cell lymphoma
The 4th International Oncology Summit 2023 - American Hospital in Dubai and Mayo Clinic - 4/30/2023
Updates in Lymphoma
6th Annual Hematology/Oncology Challenges and Advances in Patient Care for NPs, PAs, and Nurses 2023 - 4/15/2023
Best of ASH 2022-Updated about Lymphoma from ASH 2022
Mayo Clinic Florida Cancer Center Grand Round - 1/27/2023
Commonly used treatments in Lymphoma
Lymphoma Educational Series - Mayo Clinic Cancer Center - 1/11/2023
Finding Your Niche in Oncology: Careers in Academia
American Society of Clinical Oncology Meeting - 6/2022
Pola-R-CHP vs. R-CHOP
FLASCO Spring Session in Orlando - 5/7/2022
Advances in Blood Cancer Treatments at Mayo Clinic in Florida
2/16/2022
Lymphoma-Low Grade (One hour presentation to patients and care givers)
Virtual Florida Blood Cancer Conference by The Leukemia and Lymphoma Society - 2/12/2022
Real-world Utilization and Cost-effectiveness of Yttrium-90 Ibritumomab Tiuxetan vs Bendamustine Plus Rituximab for FL and MZL
Virtual - 11/16/2021
Real-World Comparison of DRd and DPd for Relapsed/Refractory MM
12/10/2020
Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/8/2019
Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Pre-clinical evaluation of high-dose Pralatrexate for CNS lymphoma
The Annual International Primary CNS Lymphoma Collaborative Group Meeting - 12/6/2019
Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
Society of hematologic oncology (SOHO) - 9/19/2014
Join now to see all

Other

Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
Alhaj Moustafa M, Rajkumar, SV, Dispenzieri, A, Buadi, F, Gertz, M, Lacy, M, Kapoor, P, Hayman, S, Dingli, D, Kyle, R, Kumar, S, Webcast Interview with The International Myeloma Foundation (IMF)
https://www.myeloma.org/videos/dr-muhamad-alhaj-moustafa-free-light-chain-measurements-myeloma-patients-ash-2014-0
American Society of Hematology (ASH) 2014 - 12/8/2014

Authored Content

A Comprehensive Review of Monoclonal Antibodies for the Treatment of Follicular Lymphoma Including Both Approved and Investigational OptionsNovember 2023
Mayo Clinic Q and A: What is lymphoma?November 2022
What is lymphoma?October 2022
My Career Path to Academia as an International Medical Graduate: Aspiration, Perseverance, and Great MentoringJanuary 2022
Presentation Tips for First-Time Abstract PresentersApril 2020
Join now to see all

Press Mentions

$Growing options for relapsed/refractory follicular lymphoma$
Growing options for relapsed/refractory follicular lymphomaSeptember 22nd, 2023
On the road againSeptember 16th, 2023
New treatment for blood cancer patientsSeptember 3rd, 2023
Join now to see all

Grant Support

Investigator-Sponsored Study GrantAcrotech Biopharma2021
The Gene and Mary Lou Kurtz Fellowship award in Multiple MyelomaMayo Clinic2014–2015

Committees

Member, Cancer Protocol Review and Monitoring Committee 2023 - Present
Member, Pharmacy and Therapeutics Committee 2022 - Present
Member, Mayo Clinic GME CLER Diversity Award selection committee 2021 - 2021
Member, ASCO Annual Meeting Education Committee - Professional Development and Education Advances 2020 - 2022
Member, Graduate Education Committee – May Clinic in Florida 2020 - 2021
Member, Mayo Clinic Florida Systemic Therapy Committee 2020 - 2021
Lead, Inpatient Taskforce for the Hematology Program at Mayo Clinic in Florida 2020 - 2021
Education Chair, Mayo Clinic Fellows Association (MFA) 2020 - 2021
Mayo Clinic Fellow Liaison, FLASCO Board of Directors 2020 - 2020
Member, ASCO Trainee Council 2019 - 2022
Member, Hematology Oncology Fellowship Program Evaluation/Education Committee at Mayo Clinic in Florida 2018 - 2021
Member, FLASCO Legislative Committee 2018 - 2021